Literature DB >> 23065717

Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion.

Tea Gogishvili1, Fred Lühder, Sandra Goebbels, Sandra Beer-Hammer, Klaus Pfeffer, Thomas Hünig.   

Abstract

While the requirement for CD28 and its ligands for the generation and function of "natural" (n)Treg cells is well established, it has not been possible yet to investigate cell-intrinsic effects after interrupted CD28 expression. Here, we demonstrate a selective loss of Treg cells after disruption of the CD28 gene. The decline in Treg-cell number was accompanied by reduced homeostatic proliferation, probably due to lack of costimulation during self-antigen recognition, and by impaired Treg-cell function including downregulation of CTLA-4. The decline in Treg-cell number was unaffected by thymectomy or by the presence of CD28 expressing T cells within the same animal, indicating that impairment of peripheral homeostasis and function of nTreg cells by CD28 deletion is cell-intrinsic. In contrast, downregulation of CD25, the α chain of the IL-2R, did not occur in the presence of WT T cells, indicating that its expression does not depend on CD28 signals in cis.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065717     DOI: 10.1002/eji.201242824

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  CD28 days later: Resurrecting costimulation for CD8(+) memory T cells.

Authors:  Verena van der Heide; Dirk Homann
Journal:  Eur J Immunol       Date:  2016-07       Impact factor: 5.532

Review 2.  Homeostatic control of regulatory T cell diversity.

Authors:  Adrian Liston; Daniel H D Gray
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

3.  Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.

Authors:  Francesco Marangoni; Ruan Zhang; Vinidhra Mani; Martin Thelen; Noor J Ali Akbar; Ross D Warner; Tarmo Äijö; Valentina Zappulli; Gustavo J Martinez; Laurence A Turka; Thorsten R Mempel
Journal:  J Immunol       Date:  2018-04-16       Impact factor: 5.422

4.  Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis.

Authors:  Jason S Ellis; So-Hee Hong; Habib Zaghouani; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

Review 5.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Regulatory T Cell Numbers in Inflamed Skin Are Controlled by Local Inflammatory Cues That Upregulate CD25 and Facilitate Antigen-Driven Local Proliferation.

Authors:  Alison C Billroth-MacLurg; Jill Ford; Alexander Rosenberg; Jim Miller; Deborah J Fowell
Journal:  J Immunol       Date:  2016-08-10       Impact factor: 5.422

Review 7.  Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.

Authors:  N Verma; S O Burns; L S K Walker; D M Sansom
Journal:  Clin Exp Immunol       Date:  2017-07-21       Impact factor: 4.330

Review 8.  CTLA-4: a moving target in immunotherapy.

Authors:  Behzad Rowshanravan; Neil Halliday; David M Sansom
Journal:  Blood       Date:  2017-11-08       Impact factor: 22.113

9.  Sequential induction of effector function, tissue migration and cell death during polyclonal activation of mouse regulatory T-cells.

Authors:  Daniela Langenhorst; Tea Gogishvili; Eliana Ribechini; Susanne Kneitz; Kirsty McPherson; Manfred B Lutz; Thomas Hünig
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Targeting co-stimulatory molecules in autoimmune disease.

Authors:  Natalie M Edner; Gianluca Carlesso; James S Rush; Lucy S K Walker
Journal:  Nat Rev Drug Discov       Date:  2020-09-16       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.